Are Thailand IVF Success Rate Data Real? – Data Sources & Statistical Methods Analysis

Direct answer opening

Direct answer: The authenticity of Thailand IVF success rate data depends on the statistical definition (clinical pregnancy rate vs. live birth rate), sample composition (age, cause of infertility, number of treatment cycles), and data source (official registry vs. self-reported by clinics). The key to objective evaluation is to look at live birth rate data stratified by age and ensure the sample size is sufficient. A single success rate number cannot be directly compared; its reference value must be assessed based on the patient's own conditions.

1. Why do success rate data published by different institutions vary so much?

Success rates published by different fertility centers in Thailand range from 40% to 80%. This variation does not fully reflect technological differences but stems more from the following core factors:

• Different statistical indicators: The clinical pregnancy rate (confirmed gestational sac by ultrasound) is usually 10–20 percentage points higher than the live birth rate (successful delivery). Some institutions publish "embryo implantation rate" or "β-hCG positive rate," which are higher but further from the final outcome of taking a baby home.
• Different patient age composition: Centers primarily treating younger patients (<35 years) may have live birth rates of 55–65%; if a center receives a large number of older or complex cases, the overall live birth rate may drop to 30–40%. Data not stratified by age is meaningless for comparison.
• Differences in transfer strategies: Centers that perform PGT (preimplantation genetic testing) on all embryos exclude chromosomally abnormal embryos, leading to higher implantation rates per single transfer, but the overall cycle success rate (due to some cycles having no usable embryos) may actually be lower.
• Data statistics period: Some institutions only count "fresh cycle" data, excluding frozen embryo transfers; others count "cumulative live birth rate per egg retrieval cycle," which yields a higher number.

2. Reference range of real success rates for patients in different age groups

According to the Thai Society for Reproductive Medicine (TSRM) and annual reports from several large centers, the approximate range of live birth rates by age (per single embryo transfer) is as follows:

*Data compiled from public reports (2022–2024) of 4 JCI-accredited centers in Thailand. Individual variations exist between centers.

3. The most easily overlooked detail: What is the "denominator" of the data statistics?

When judging data authenticity, a key question is: What is the denominator of the "success rate"?

• Cumulative live birth rate per egg retrieval cycle (CLBR): Refers to the probability of achieving a live birth from all fresh and frozen embryo transfers following one egg retrieval. This indicator best reflects the overall efficiency of a cycle and is usually 10–20% higher than the per-transfer rate.
• Live birth rate per transfer: Only counts cycles where "embryos are available for transfer," excluding cases with no usable embryos. For older or poor ovarian response patients, this indicator can be artificially inflated.
• Live birth rate per patient: Counts the probability of a live birth after a patient completes all treatments. This is closest to the true outcome but is less frequently published alone by institutions.

If one institution publishes a "live birth rate per transfer" and another publishes a "live birth rate per egg retrieval cycle," the former may be 10–15 percentage points higher, but it does not necessarily mean better technology.

4. How do doctors view success rate data?

In clinical decision-making, reproductive doctors do not rely solely on the success rate numbers published by institutions to evaluate treatment plans. Doctors pay more attention to the following indicators:

• Patient's own conditions: Individual factors such as AMH, antral follicle count, age, and previous IVF history have a far greater impact on outcomes than the institution's average data.
• Laboratory quality: Process indicators like blastocyst formation rate, good-quality embryo rate, and freeze-thaw survival rate reflect the true level of the laboratory better than the final success rate.
• Data consistency: If a center's live birth rate has remained stable for 3–5 consecutive years and age-stratified data is complete, its credibility is higher. If data fluctuates sharply in a particular year, the reason needs to be investigated.

5. Where do data differences between different hospitals actually come from?

The technology platforms and laboratory standards of major fertility centers in Thailand are generally similar, but data differences still exist, mainly due to:

• Patient selection criteria: Some centers strictly select patients with normal ovarian reserve and no complex medical history, naturally resulting in higher data. Centers that accept older patients, those with repeated failures, or complex cases will have their overall data pulled down.
• PGT usage rate: Centers that routinely perform PGT have higher implantation rates per single transfer, but the overall number of cycles increases, and the cumulative live birth rate may be higher or lower depending on patient age.
• Transfer strategy: Centers favoring elective single embryo transfer (eSET) have slightly lower live birth rates but lower multiple birth rates; centers performing multiple embryo transfers have slightly higher live birth rates per transfer but increased risk of multiple pregnancies.
• Data audit method: Centers with international accreditation (e.g., JCI, RTAC) have their data regularly audited by third parties, making it more authentic. Institutions without external audits may selectively report data.

6. Common pitfalls: Being misled by "packaged data"

In practice, special attention should be paid to the following types of data statements:

• "Success rate as high as 85%": Usually refers to the clinical pregnancy rate for patients under 35, not the overall live birth rate. This data is completely inapplicable to patients over 40.
• "Our center completes XX cases annually, with an industry-leading success rate": Data that does not specify the statistical definition, provide age stratification, or disclose sample size is invalid data.
• "Embryo implantation rate after genetic screening is 90%": The implantation rate after PGT is indeed higher, but this ignores cases where "no embryos are available for transfer." For older patients, 30–50% of cycles may have no usable embryos after PGT.
• "Real data, verifiable": When requesting raw data, confirm whether it includes data from all started cycles, not just data from "good prognosis cases."

7. How to judge whether a set of Thailand IVF data is reliable

To evaluate the reliability of a set of success rate data, follow these steps:

1. Confirm the statistical indicator: Is it "live birth rate" or "clinical pregnancy rate"? Is it "per transfer" or "per egg retrieval cycle"?
2. Check age stratification: Is it grouped as <35, 35–38, 39–41, 42–44, >44? Is the sample size per group ≥50?
3. Verify the data source: Does the data come from the institution's internal statistics or a third-party registry (e.g., TSRM, JCI audit reports)?
4. Examine data consistency: Has the data from the same institution been stable over the past 3–5 years? Are there any sudden large increases or decreases?
5. Ask about exclusion criteria: Were cancelled cycles, cycles with no eggs retrieved, or cycles with no embryos excluded? What are these exclusion rates?
6. Compare multiple independent data sources: Are the data from different centers in the same region within a reasonable range? If one center's data is significantly higher than its peers, the reason needs to be investigated.

By following these six steps, most misleading data can be filtered out, providing a reference range closer to the true success rate.

8. Special case handling: Different data reference methods for certain groups

The following groups need to adjust their evaluation methods when referencing Thailand IVF success rate data:

• Patients with poor ovarian response (POR): AMH < 0.5 ng/mL, antral follicle count < 5. The overall live birth rate may be 10–15 percentage points lower than the institution's average. Focus on "cumulative live birth rate per egg retrieval cycle."
• Patients with recurrent implantation failure (RIF): ≥3 previous failed transfers. Pay attention to the institution's specific data for RIF patients, not the overall data.
• Older patients (≥42 years) using own eggs: The live birth rate per cycle is usually < 15%. Consult the institution about "cumulative live birth rate" and "multi-cycle strategy" data.
• Patients requiring egg donation: Success rate data should be based on independent data from "donor egg cycles," not autologous egg cycle data.

9. Frequently asked questions: Most common data-related questions from patients

• Q: "Is the IVF success rate in Thailand really higher than in my home country?"
  A: Under the same age and diagnostic conditions, the live birth rates at some Thai centers are similar to leading centers in other countries. Differences mainly arise from statistical definitions, patient selection, and PGT usage strategies, not technological gaps. Use age-stratified live birth rate data for comparison.
• Q: "The clinic says the success rate is 80%, so why did my friend fail?"
  A: The success rate is a population statistical concept and does not represent an individual outcome. An 80% success rate means 2 out of 10 people fail; individual failure is within the normal probability range. The key is whether the institution has honestly disclosed data stratification and sample size.
• Q: "Where can I find the real success rate data for Thailand IVF?"
  A: The TSRM annual report, public audit data from JCI-accredited institutions, and clinical studies published by large centers in PubMed are relatively reliable independent data sources. Data on institution websites should be verified using the methods above.
• Q: "Do hospitals with good data have long waiting lists?"
  A: Some centers with high data transparency do have more patients, potentially leading to longer waiting times. However, waiting time is not directly related to success rate; you need to weigh data reliability against time costs.

10. Practitioner observation: What you need to know about Thailand IVF data

Through collaboration with multiple fertility centers in Thailand, the following observations have been made:

• Thailand does not have a mandatory national assisted reproductive technology data registry; data submission by centers is voluntary, resulting in a lack of uniform audit standards.
• Centers accredited by JCI or RTAC have relatively standardized data management, and their live birth rate data is closer to the true level.
• Some centers distinguish between "local Thai patients" and "international patients" data, which may differ (international patients tend to be older and have more complex cycles).
• Since 2023, several leading Thai centers have begun publishing age-stratified live birth rate data and undergoing third-party audits, which is a positive trend.
• The most reliable way to evaluate data is still to ask the institution to provide subgroup data matching your own age, diagnosis, and AMH level, and request the sample size.

Suggested next steps: Obtain your basic test results including AMH, antral follicle count, semen analysis, and karyotype. Then, select 2–3 Thai fertility centers with high data transparency for remote consultations. Request each to provide subgroup live birth rate data matching your conditions, compare them, and then make a decision.